Core Viewpoint - Xiamen Jindawei Group Co., Ltd. has received a patent for a method and device for preparing 7-dehydrocholesterol and vitamin D3, which enhances the yield and purity of 7-dehydrocholesterol, contributing to the company's technological innovation and intellectual property protection [1][2]. Summary by Relevant Sections - **Patent Details** - Patent Name: A method and device for preparing 7-dehydrocholesterol and vitamin D3 [1] - Patent Number: ZL 2023 1 0125624.5 [1] - Application Date: February 16, 2023 [1] - Patent Holder: Xiamen Jindawei Vitamin Co., Ltd. [1] - Patent Term: Twenty years [1] - Certificate Number: 8222940 [1] - Authorization Announcement Date: September 5, 2025 [1] - **Technical Significance** - The invention belongs to the field of organic synthesis and aims to improve the yield and purity of 7-dehydrocholesterol [1]. - **Impact on Company** - The acquisition of the patent is not expected to have a significant impact on the company's production and operations but is beneficial for technological innovation and enhancing core competitiveness through intellectual property [1].

Group 1 - The chairman of the board, Mr. Wu Xingwang, has submitted a written report to resign from his positions due to work adjustments [1] - Mr. Wu's resignation will not affect the minimum number of board members or the normal operation of the board and company management [1] - The company will complete the election of a new chairman in accordance with legal procedures [1] Group 2 - Mr. Wu has made significant contributions to the company's operational development during his tenure as chairman, and the board expresses gratitude for his efforts [2]

Core Points - Linzhou Heavy Machinery Group Co., Ltd. announced the release and re-pledging of shares held by its controlling shareholder, Guo Xiansheng [1] - The total number of shares released from pledge is 13,000,000, which accounts for 5.49% of the total shares held by Guo Xiansheng [1] - As of the announcement date, the cumulative pledged shares by the controlling shareholder and its concerted parties amount to 243,550,160, representing 76.85% of their total holdings [2] Summary by Sections 1. Pledge Release Details - Guo Xiansheng, the controlling shareholder, released 13,000,000 shares from pledge, which is 1.62% of the company's total share capital [1] - The shares were pledged to Huzhou Economic Development Zone Yongxin Small Loan Co., Ltd. [1] 2. Cumulative Pledge Situation - As of the announcement date, the total pledged shares by the controlling shareholder and its concerted parties are 316,900,058, which is 39.53% of the total shares [2] - The pledged shares do not currently pose a risk of being forced to sell [2] 3. Other Information - The company will continue to monitor the pledge situation and adhere to relevant regulations, ensuring timely information disclosure [2]

Group 1 - The core point of the news is that Jiaze Renewables Corporation is planning to issue shares to specific investors, with the underwriting by Guotai Haitong Securities Co., Ltd. [1][2] - The total share capital of Jiaze Renewables Corporation is 2,434,362,939 yuan as of June 30, 2025 [3]. - The company is primarily engaged in the investment, construction, operation, and sale of renewable energy power plants, including solar, wind, and biomass energy [3]. Group 2 - The issuance will be conducted through a private placement to the controlling shareholder's wholly-owned subsidiary, with a subscription amount of 120 million yuan [6][8]. - The issue price is set at 2.51 yuan per share, which is not less than 80% of the average trading price over the previous 20 trading days [6][7]. - The maximum number of shares to be issued is estimated at 478,087,649 shares, which does not exceed 30% of the total share capital prior to the issuance [8][20]. Group 3 - The funds raised will be used to supplement working capital and repay bank loans, enhancing the company's financial strength and capital structure [16][19]. - The company has a history of issuing shares and convertible bonds, with the last private placement occurring more than 18 months prior to this issuance [21]. - The issuance complies with the relevant laws and regulations, including the Securities Law and the Registration Management Measures [15][17].

Group 1 - The company has signed a total of 101,735 million yuan contract for the production of metamaterial products with one client and an additional 127,780.38 million yuan contract with four other clients [1][2] - The total amount for the contracts with five clients is 127,780.38 million yuan, with delivery expected to be completed by June 30, 2026 [1] - The contracts include clear agreements on delivery, pricing, quality requirements, technical standards, packaging standards, acceptance standards, settlement methods and deadlines, breach of contract responsibilities, and dispute resolution [1] Group 2 - The signing and execution of these contracts are expected to impact the company's operating performance for the current year and 2026 [2] - The company will continue to invest in the research, development, production, and testing of metamaterials to enhance the market competitiveness of next-generation metamaterial aerospace structures [1][2] - The company maintains that the execution of these contracts will not affect its business independence and will not create dependency on the related clients [2]

Core Viewpoint - The company, Gansu Guofang Industry and Trade (Group) Co., Ltd., is set to hold a half-year performance briefing on September 12, 2025, to discuss its 2025 first-half performance and address investor inquiries [1][2]. Group 1: Meeting Details - The performance briefing will take place on September 12, 2025, from 15:00 to 16:00 [2][3]. - The meeting will be conducted in an online interactive format via the Shanghai Securities Journal and China Securities Network [2][3]. - Investors can submit their questions via email to the company's investor relations email (IR@guofanggroup.com) by September 11, 2025, at 18:00 [2][3]. Group 2: Participants - Key participants in the meeting will include Chairman Zhang Huiyang, General Manager Zhang Hui, Independent Director Li Zongyi, Financial Director Li Yuan, and Secretary of the Board Ma Lin [2][3]. Group 3: Contact Information - For inquiries, investors can contact the Securities Affairs Department at phone number 0931-8803 618 or via email at IR@guofanggroup.com [3].

证券代码：001206 证券简称：依依股份 公告编号：2025-058 天津市依依卫生用品股份有限公司 关于参加 2025 年天津辖区上市公司投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 天津市依依卫生用品股份有限公司（以下简称"公司"）已于 2025 年 8 月 22 日披露了《天津市依依卫生用品股份有限公司 2025 年半年度报告》全文及摘要， 为进一步加强与投资者的互动交流，公司将参加由天津证监局指导、天津上市公司 协会及深圳市全景网络有限公司联合协办的"2025 年天津辖区上市公司投资者网上 集体接待日活动"，现将有关事项公告如下： 本 次活 动将采用 网 络远程的方 式举行，投资 者可登录 "全景路 演 "网站 （http://rs.p5w.net）；或关注微信公众号（名称：全景财经）；或下载全景路演 APP， 参与本次互动交流。本次网上互动交流时间为 2025 年 9 月 11 日（星期四）15:00-17:00。 届时公司董事长兼总经理高福忠先生、董事会秘书兼财务总监周丽娜女士、独 立董事刘颖女士将在线就公司 ...

Core Viewpoint - The report outlines the continuous supervision and compliance of Suzhou Nearshore Protein Technology Co., Ltd. after its IPO on the Sci-Tech Innovation Board, emphasizing the company's adherence to regulations and its operational performance despite financial losses. Continuous Supervision Work - The sponsor has established a robust continuous supervision system and work plan for the company, ensuring compliance with relevant regulations and effective communication [1][2] - The sponsor conducted regular visits, due diligence, and checks to monitor the company's operations and compliance with laws and regulations [1][2] - Throughout the supervision period, the company did not encounter any violations or breaches of commitments that required public disclosure [1][2] Financial Performance - For the first half of 2025, the company reported revenue of approximately 72.09 million, a year-on-year increase of 20.85% [8] - The net loss attributable to shareholders was approximately 24.22 million, with a net profit excluding non-recurring items of about -26.68 million [8] - The company’s cash flow from operating activities was -14.08 million, indicating a significant decline compared to the previous year [8] Core Competitiveness - The company has developed seven comprehensive technology platforms and 23 core technologies, which are crucial for maintaining its market competitiveness [5][9] - The company emphasizes the importance of protecting its core technologies to prevent leakage, which could adversely affect its operations [5][9] - A skilled and stable technical team is essential for sustaining technological leadership and core competitiveness [5][9] Industry Risks - The RNA vaccine and drug industry is still maturing, with uncertainties in demand for mRNA raw materials and reagents in various applications [7][8] - The company faces intense competition from both domestic and international players, which could impact its market position and profitability [6][7] Research and Development - The company invested approximately 26.1 million in R&D in the first half of 2025, accounting for 36.21% of its revenue, reflecting a slight decrease from the previous year [16] - As of June 30, 2025, the company holds 38 invention patents, 22 utility model patents, and 18 software copyrights, indicating a strong focus on innovation [16] Use of Raised Funds - The company raised approximately 186.30 million through its IPO, with 174.22 million remaining after deducting issuance costs, and has complied with regulations regarding the use of these funds [17][18]

Group 1 - The financial advisor, Guojin Securities, has been appointed by Shenzhe Ruitai to oversee the equity change of Honghui Fruits and Vegetables Co., Ltd. and will perform continuous supervision for 12 months after the completion of the equity change [1][2] - Shenzhe Ruitai plans to acquire 151,380,521 shares of Honghui Fruits and Vegetables at a price of 5.68 yuan per share, which represents 26.54% of the total share capital [4][5] - Following the completion of the share transfer, Huang Junhui will permanently waive voting rights for 68,446,355 shares (12% of total share capital) to ensure that his voting rights do not exceed 8% [4][5] Group 2 - The share transfer has been completed, with the share registration date set for July 24, 2025, and the voting rights waiver effective from August 22, 2025 [4][5] - After the equity change, Shenzhe Ruitai will become the controlling shareholder of Honghui Fruits and Vegetables, with Ye Tao, Liu Yang, and Suzhou Asset Management Group as the actual controllers [4][5] - During the continuous supervision period, both Shenzhe Ruitai and Honghui Fruits and Vegetables have complied with legal and regulatory requirements, maintaining a good corporate governance structure [5][6] Group 3 - There are no plans for significant adjustments to the main business of Honghui Fruits and Vegetables in the next 12 months, nor any plans for asset sales, mergers, or acquisitions [11][12] - The board of directors and senior management of Honghui Fruits and Vegetables have not undergone any adjustments during the continuous supervision period [12][13] - No changes to the company's articles of association or significant adjustments to employee hiring or dividend policies are planned in the near future [12][13][14]

Core Viewpoint - The legal opinion letter from Zhonglun Law Firm confirms that the 2023 Restricted Stock Incentive Plan of Ice Wheel Environmental Technology Co., Ltd. has met the necessary legal requirements and conditions for unlocking the first lock-up period of the granted restricted stocks [2][26]. Group 1: Legal Compliance and Approval - The legal opinion letter states that the company has fulfilled the necessary legal procedures for the unlocking of the restricted stocks and the adjustments and repurchase of certain restricted stocks [12][26]. - The company has provided all necessary original documents and evidence to support the legal opinion, ensuring no false or misleading statements are present [4][5]. Group 2: Unlocking Conditions - The first lock-up period for the restricted stocks is set to last from the completion of registration for 24 months until the last trading day within 36 months, with a 40% unlock ratio of the total granted restricted stocks [12][16]. - The conditions for unlocking the restricted stocks include the absence of negative audit opinions and compliance with performance assessment targets set for the years 2023-2025 [12][13]. Group 3: Performance Assessment - The company achieved a profit growth rate of 131.28% from 2019 to 2023, exceeding the assessment target of 34% [12][13]. - The average return on equity and asset-liability ratio also met the required benchmarks, confirming the fulfillment of performance assessment conditions for unlocking [13][14]. Group 4: Adjustments and Repurchase - The adjustments to the restricted stock repurchase price and quantity are based on the company's profit distribution and capital reserve transfer plans, ensuring compliance with relevant laws and regulations [20][26]. - The repurchase price for the restricted stocks has been adjusted to 5.77 yuan per share, considering the company's profit distribution and capital reserve adjustments [25][26].